JP Morgan Chase’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.8M | Sell |
685,666
-279,393
| -29% | -$884K | ﹤0.01% | 4180 |
|
|
2025
Q4 | $3.57M | Buy |
965,059
+19,568
| +2% | +$63.2K | ﹤0.01% | 3618 |
|
|
2025
Q3 | $2.51M | Buy |
945,491
+384,095
| +68% | +$743K | ﹤0.01% | 3911 |
|
|
2025
Q2 | $553K | Sell |
561,396
-1,360,311
| -71% | -$1.36M | ﹤0.01% | 4724 |
|
|
2025
Q1 | $2.77M | Sell |
1,921,707
-532,509
| -22% | -$981K | ﹤0.01% | 3620 |
|
|
2024
Q4 | $5.4M | Buy |
2,454,216
+385,099
| +19% | +$898K | ﹤0.01% | 3271 |
|
|
2024
Q3 | $3.41M | Buy |
2,069,117
+19,588
| +1% | +$39.6K | ﹤0.01% | 3526 |
|
|
2024
Q2 | $4.55M | Sell |
2,049,529
-35,572
| -2% | -$83.7K | ﹤0.01% | 3101 |
|
|
2024
Q1 | $5.59M | Buy |
2,085,101
+222,631
| +12% | +$541K | ﹤0.01% | 3004 |
|
|
2023
Q4 | $5.57M | Sell |
1,862,470
-1,862
| -0.1% | -$2.42K | ﹤0.01% | 2980 |
|
|
2023
Q3 | $1.83M | Buy |
1,864,332
+1,640,585
| +733% | +$2.37M | ﹤0.01% | 3604 |
|
|
2023
Q2 | $311K | Buy |
223,747
+36,952
| +20% | +$51.6K | ﹤0.01% | 4794 |
|
|
2023
Q1 | $297K | Sell |
186,795
-189,051
| -50% | -$976K | ﹤0.01% | 4816 |
|
|
2022
Q4 | $2.34M | Sell |
375,846
-24,990
| -6% | -$179K | ﹤0.01% | 3441 |
|
|
2022
Q3 | $2.69M | Sell |
400,836
-479,687
| -54% | -$3.29M | ﹤0.01% | 3227 |
|
|
2022
Q2 | $5.6M | Buy |
880,523
+126,683
| +17% | +$718K | ﹤0.01% | 2691 |
|
|
2022
Q1 | $3.5M | Buy |
753,840
+636,537
| +543% | +$2.73M | ﹤0.01% | 3306 |
|
|
2021
Q4 | $587K | Buy |
117,303
+30,848
| +36% | +$247K | ﹤0.01% | 4722 |
|
|
2021
Q3 | $1.04M | Buy |
86,455
+11,380
| +15% | +$166K | ﹤0.01% | 4279 |
|
|
2021
Q2 | $1.59M | Sell |
75,075
-49,712
| -40% | -$1.2M | ﹤0.01% | 3958 |
|
|
2021
Q1 | $3.5M | Sell |
124,787
-6,543
| -5% | -$193K | ﹤0.01% | 3273 |
|
|
2020
Q4 | $3.42M | Sell |
131,330
-2,578
| -2% | -$77.2K | ﹤0.01% | 3098 |
|
|
2020
Q3 | $5.02M | Sell |
133,908
-8,413
| -6% | -$333K | ﹤0.01% | 2571 |
|
|
2020
Q2 | $7.3M | Buy |
142,321
+6,760
| +5% | +$283K | ﹤0.01% | 2155 |
|
|
2020
Q1 | $4.28M | Buy |
135,561
+34,255
| +34% | +$1.81M | ﹤0.01% | 2399 |
|
|
2019
Q4 | $6.04M | Sell |
101,306
-36,491
| -26% | -$1.64M | ﹤0.01% | 2542 |
|
|
2019
Q3 | $5.05M | Sell |
137,797
-3,028
| -2% | -$120K | ﹤0.01% | 2695 |
|
|
2019
Q2 | $6.88M | Buy |
140,825
+59,425
| +73% | +$2.79M | ﹤0.01% | 2391 |
|
|
2019
Q1 | $3.27M | Sell |
81,400
-122,038
| -60% | -$5.47M | ﹤0.01% | 2950 |
|
|
2018
Q4 | $9.36M | Buy |
203,438
+132,343
| +186% | +$6.38M | ﹤0.01% | 2068 |
|
|
2018
Q3 | $3.15M | Buy |
71,095
+2,348
| +3% | +$108K | ﹤0.01% | 3117 |
|
|
2018
Q2 | $2.69M | Sell |
68,747
-177,504
| -72% | -$8.97M | ﹤0.01% | 3171 |
|
|
2018
Q1 | $17.8M | Buy |
246,251
+163,990
| +199% | +$12M | ﹤0.01% | 1589 |
|
|
2017
Q4 | $5.42M | Buy |
82,261
+20,461
| +33% | +$1.1M | ﹤0.01% | 2622 |
|
|
2017
Q3 | $3.09M | Sell |
61,800
-107,000
| -63% | -$5.16M | ﹤0.01% | 2900 |
|
|
2017
Q2 | $7.81M | Sell |
168,800
-15,108
| -8% | -$556K | ﹤0.01% | 2152 |
|
|
2017
Q1 | $6.49M | Sell |
183,908
-12,592
| -6% | -$288K | ﹤0.01% | 2252 |
|
|
2016
Q4 | $2.46M | Buy |
196,500
+15,100
| +8% | +$180K | ﹤0.01% | 2935 |
|
|
2016
Q3 | $2.51M | Buy |
181,400
+39,239
| +28% | +$445K | ﹤0.01% | 2666 |
|
|
2016
Q2 | $1.4M | Buy |
142,161
+42,361
| +42% | +$702K | ﹤0.01% | 2992 |
|
|
2016
Q1 | $1.69M | Sell |
99,800
-9,700
| -9% | -$156K | ﹤0.01% | 2790 |
|
|
2015
Q4 | $2.44M | Sell |
109,500
-94,831
| -46% | -$2.39M | ﹤0.01% | 2650 |
|
|
2015
Q3 | $4.82M | Buy |
+204,331
| New | +$12.8M | ﹤0.01% | 2246 |
|
|
2015
Q2 | – | Sell |
-107,674
| Closed | -$9.97M | – | 4058 |
|
|
2015
Q1 | $9.97M | Buy |
+107,674
| New | +$6.95M | ﹤0.01% | 1901 |
|
Other funds holding ESPR
WA
TSC
O
VCM
